Go to the list of all blogs
Sarah Patel's Avatar
published in Blogs
Apr 01, 2021

J&J (JNJ, $164.62) vaccine supply halted, after mix-up at Emergent BioSolutions (EBS, $92.94) plant

A mix-up of ingredients of Johnson & Johnson’s  ( J&J ) COVID-19 vaccine and Astra Zeneca’s at an Emergent BioSolutions (EBS)  manufacturing plant in Maryland ruined 15 million doses of J&Js   vaccine, leading to deliveries getting halted.

The mix-up occurred about two weeks ago, and all shipments  from the plant have been halted by the Food and Drug Administration. The latter in probing into the matter.

Last July, Emergent BioSolutions signed a contract, for a deal worth $480 million over the first two years, to make vaccine components for J&J .

While currently distributed J&J vaccines are not affected, the plant is supposed to produce millions of the single-shot vaccines which are expected to help the U.S. scale up its COVID-19 vaccinations in coming weeks.

EBS has manufacturing deals with several other pharmaceutical companies for vaccines including Novavax ,  Vaxart Inc., and Humanigen.

Related Ticker: EBS

EBS in -12.06% downward trend, declining for three consecutive days on October 03, 2023

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where EBS declined for three days, in of 306 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 11, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on EBS as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Aroon Indicator for EBS entered a downward trend on October 03, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for EBS just turned positive on September 28, 2023. Looking at past instances where EBS's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EBS advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.171) is normal, around the industry mean (86.487). P/E Ratio (17.730) is within average values for comparable stocks, (58.641). EBS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.372). EBS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (0.148) is also within normal values, averaging (62.270).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.6B. The market cap for tickers in the group ranges from 246 to 79.51B. ZTS holds the highest valuation in this group at 79.51B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 25%. For the same Industry, the average monthly price growth was 30%, and the average quarterly price growth was 13%. INNPF experienced the highest price growth at 8,038%, while RDHL experienced the biggest fall at -41%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was -21% and the average quarterly volume growth was 61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 70
Price Growth Rating: 59
SMR Rating: 84
Profit Risk Rating: 92
Seasonality Score: -1 (-100 ... +100)
Related Portfolios: BIOTECHNOLOGY SECTOR
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Professional Drive
Phone
+1 240 631-3200
Employees
2500
Web
https://www.emergentbiosolutions.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBLRX12.31-0.13
-1.05%
BBH Select Series - Large Cap Retail
GRSPX21.87-0.27
-1.22%
Cromwell Greenspring Mid Cap Instl
GSCGX26.26-0.39
-1.46%
Goldman Sachs Large Cap Core A
AVPAX21.34-0.36
-1.66%
American Beacon Small Cp Val Inv
RYKIX66.43-1.32
-1.95%
Rydex Banking Inv

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with ELAN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
-5.38%
ELAN - EBS
44%
Loosely correlated
-4.20%
SIGA - EBS
38%
Loosely correlated
+0.10%
SUPN - EBS
38%
Loosely correlated
N/A
DVAX - EBS
37%
Loosely correlated
-3.74%
EVO - EBS
35%
Loosely correlated
-1.69%
More
Artificial intelligence (AI) and fintech have an inherent compatibility that has become clearer as each sector has matured, with recent growth and successes on their own accord bringing new ideas about how they can work together.AI can analyze information at far greater quantities (and far more quickly) than any human, making it a natural fit to help fintech firms streamline and automate processes that benefit customers and businesses alike. Fintech has brought a revolution of convenience to the finance world.
You’ve set up your bitcoin wallet and have acquired some bitcoins, and now you’re ready to use them – what’s next?But be VERY careful to double- or triple-check that the address is correct – crypto transactions are irreversible, and a typo almost certainly means permanently losing the bitcoins you were trying to send. One way to avoid potential slip-ups is to scan a QR code (when available) for the destination address.
Mainstream acceptance has come in fits and starts, with regulatory approval proving hard to come by for a variety of reasons – not least of which the ever-present risk of theft via hacking or other means, which pose an especially large obstacle to attracting investment from mainstream institutions. Because crypto holdings are only accessible via a specific private key, they are susceptible to loss – literally, if the key is written on a piece of paper or a physical hard drive, methods of offline ‘cold storage’ – or through hacks if held in an online wallet.Reuters reports that over $800 million in crypto assets were stolen in the first half of 2018, creating justifiable concern for both owners and mainstream financial institutions alike. Some type of insurance coverage would potentially mitigate the risks inherent to owning crypto assets – if insurers are willing to play ball.
Don't fall prey to common financial traps that can derail your financial planning efforts. In this article, we highlight four traps to keep in mind, including the importance of refinancing rather than consolidating student loans and credit card debt, prioritizing debt repayment over investments, limiting news consumption, and understanding the true costs of buying a home. Learn how AI tools from Tickeron can help investors make informed decisions and achieve their investment objectives.
Paper wallets are extremely useful tools – beyond being one of the most popular and secure cold storage methods, they make it simple to transfer coins between owners.You can access the funds on your paper wallet by “sweeping” (or importing) them to either a live wallet (like Trezor or Exodus) or an exchange service (like Coinbase). Most services allow you to import them directly from your wallet’s private key, but there are two key exceptions.
Get ready to revolutionize your investment strategy! Discover 3 cutting-edge ways to get fresh and innovative investment ideas, and say goodbye to relying on unreliable sources like CNBC. From utilizing advanced AI tools to sharing your portfolio with trusted friends, these methods are sure to boost your investment game. So, what are you waiting for? Read on to find out how you can start generating new ideas today!
You’re a trader, not an investor. It’s important that you understand the difference before choosing an actual trading style. Traders perform their magic over shorter periods of time, sometimes within minutes or hours. Investors are more passive. They purchase equities and hold them for months or years, relying on a long-term return. Traders evaluate buys and sells based on technical analysis...
Looking to invest your money in the stock market? While leaving your money there for a few years can yield a ten percent return, real traders know that actively trading and using derivatives is the way to make a significant profit while minimizing risk. Derivatives are contracts between two parties that are based on the price of a financial asset, such as a stock or bond. The value of the...
Zoom (ZOM), the video conferencing giant, registered a three-day uptrend of +1.84%. Our proprietary AI trading bot identified an intraday gain of 6.75%, attributing it to robust market sentiment and promising growth indicators. This uptrend signals a potentially strong position for investors and stakeholders. A deeper analysis could provide crucial insights into the future performance of ZOM. Stay updated for further analytics and forecast from our AI tools.
The Swing Trader: Volatility Balanced Strategy (TA) AI trading robot has emerged as a remarkable performer. Operating within our robot factory, this trading algorithm has recently demonstrated its prowess by generating a notable gain of 3.74% while trading ZIM (ZIM Integrated Shipping Services Ltd) over the previous week. This article aims to delve into the technical analysis surrounding ZIM's recent performance and the potential for an impending price rebound.
AI trading robot, the Swing trader: Volatility Balanced Strategy (TA), has stood out as a performer in our robot factory. In the previous week, it achieved an impressive 3.78% gain while trading AFRM (Affirm Holdings Inc.), a notable stock in the market. In this article, we will delve into the technical analysis of AFRM's recent movements and explore the implications of its earnings results.
Among them, the Swing Trader: Volatility Balanced Strategy (TA) stands out as a top-performing AI trading robot. In the previous week, this robot demonstrated its prowess by generating an impressive 3.60% gain while trading NET (stock ticker symbol) – a remarkable achievement. This article delves into the reasons behind the success of Swing Trader, focusing on the positive Moving Average Convergence Divergence (MACD) indicator and the recent earning results of NET.
The Swing Trader: Volatility Balanced Strategy (TA), has caught our attention for its impressive performance. Last week, it generated a remarkable gain of 3.56% while trading RIOT, a prominent stock. In this article, we will delve into the analysis of RIOT's recent bearish trend and examine the company's earnings results, which exceeded expectations.
The Swing Trader: Volatility Balanced Strategy (TA) AI trading robot has emerged as a top performer in our robot factory, demonstrating exceptional performance and generating significant gains. In the previous week, this intelligent trading bot achieved a remarkable 3.56% gain while trading WKHS (Workhorse Group Inc.) - an achievement worth noting. Coupled with positive market indicators, WKHS presents an intriguing opportunity for potential future growth.
AI trading robot, known as "Swing trader: Volatility Balanced Strategy (TA)," has caught the attention of traders and investors alike. In the previous week, this AI robot, developed in our esteemed robot factory, demonstrated impressive performance by generating a gain of 3.51% while trading DKNG. This article will delve into the recent trading activity, the significance of the stock's upward trend, and analyze the latest earnings results of DKNG.
One such tool that has garnered attention is the AI trading robot known as Swing trader: Volatility Balanced Strategy (TA). This robot, developed in our esteemed factory, recently demonstrated its prowess by generating a notable 3.02% gain while trading CHPT (ChargePoint Holdings) over the previous week. While CHPT experienced a downward trend, the robot's performance and insightful analysis provide valuable insights for traders and investors alike.
Explore the financial battleground between JNJ, a medium-volatility swing trading choice, and MRK, a popular stock for trend trading. Delving into their current performances, JNJ shows a gain of 3.04% while MRK rises by 6.71%. The analysis combines Technical Analysis (TA) & Fundamental Analysis (FA) for precise forecasting. Gain insights into market trends, financial stability, and future stock movement predictions for informed investment decisions.
Dive into a comparative analysis between the Market Neutral Strategy applied to CCL (yielding 15.39%) and the Swing Trading Strategy applied to MULN (yielding 19%). Both employ technical and fundamental analysis. Discover how the Motor Vehicles sector (+2.11% weekly) and Other Consumer Services (+3.75% weekly) affect these strategies. Earnings for CCL and MULN are expected on Sep 28 and May 31 respectively
Apple (AAPL) has entered a monthly bullish trend, and A.I.dvisor predicts that the stock will continue its upward trajectory. With a projected growth of 4% or more within the next month, AAPL investors may have reasons to be optimistic about its Uptrend continuation.
General Electric (GE) has entered a monthly bullish trend, signaling potential for an Uptrend continuation. With A.I.dvisor predicting a projected growth of 4% or more within the next month, GE investors may anticipate further positive momentum in the stock.